- Home
- CODX vs TRIB Comparison
CODX vs TRIB Comparison
Compare CODX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- TRIB
- Stock Information
- Founded
- CODX 2013
- TRIB 1992
- Country
- CODX United States
- TRIB Ireland
- Employees
- CODX N/A
- TRIB N/A
- Industry
- CODX Medical/Dental Instruments
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CODX Health Care
- TRIB Health Care
- Exchange
- CODX Nasdaq
- TRIB Nasdaq
- Market Cap
- CODX 15.6M
- TRIB 18.3M
- IPO Year
- CODX 2017
- TRIB N/A
- Fundamental
- Price
- CODX $0.33
- TRIB $0.87
- Analyst Decision
- CODX Buy
- TRIB
- Analyst Count
- CODX 2
- TRIB 0
- Target Price
- CODX $2.00
- TRIB N/A
- AVG Volume (30 Days)
- CODX 61.3M
- TRIB 75.4K
- Earning Date
- CODX 11-13-2025
- TRIB 11-14-2025
- Dividend Yield
- CODX N/A
- TRIB N/A
- EPS Growth
- CODX N/A
- TRIB N/A
- EPS
- CODX N/A
- TRIB N/A
- Revenue
- CODX $507,892.00
- TRIB $61,555,000.00
- Revenue This Year
- CODX N/A
- TRIB $13.51
- Revenue Next Year
- CODX $31.58
- TRIB $13.14
- P/E Ratio
- CODX N/A
- TRIB N/A
- Revenue Growth
- CODX N/A
- TRIB 8.31
- 52 Week Low
- CODX $0.23
- TRIB $0.48
- 52 Week High
- CODX $1.55
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- CODX 44.98
- TRIB 34.35
- Support Level
- CODX $0.38
- TRIB $0.84
- Resistance Level
- CODX $0.40
- TRIB $0.97
- Average True Range (ATR)
- CODX 0.07
- TRIB 0.06
- MACD
- CODX -0.02
- TRIB -0.01
- Stochastic Oscillator
- CODX 2.26
- TRIB 20.32
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.